Close Search

Honors & Awards


  • $177,512.00
    Sanjay Menghani
    Copper Chelating Compounds as Novel Antimicrobial Class
    Research Training
  • $119,319.00
    Jerome Lacombe
    Investigation of Stereotactic Ablative Radiation Treatment in Combination With Anti-pd1 Immunotherapy for Lung Cancer by Using an Innovative Tumor-on-chip Technology
    COM Phx NanoBioscience & Med
  • $737,974.00
    Sairam Parthasarathy
    A Phase Two Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients with Respiratory Distress due to COVID-19 Infection



Expert Insights: What to know about a kissing bug bite

In The Media

  • CBS News - June 7

    Dr. Shad Marvasti, an associate professor and director of public health, prevention and population health curriculum at the College of Medicine – Phoenix, discusses the slowing pace of coronavirus vaccinations in the U.S. as President Biden's July 4 goal nears. 

  • Dr. John Galgiani, a professor of medicine in infectious diseases at the College of Medicine – Tucson and director of the Valley Fever Center for Excellence, says this year Valley Fever is heading for the highest case count in the last ten years.

  • David Harris, professor of immunobiology and executive director of the UArizona Biorepository in the College of Medicine –Tucson, said there is some encouraging data to support the ability of mesenchymal stem cells to treat various conditions such as an open wound. Harris also said there's no conclusive scientific proof yet that they work and that studies are still ongoing.


Grand Rounds